Agency Information Collection Request; 30-Day Public Comment Request, 44891-44892 [2018-19084]

Download as PDF 44891 Federal Register / Vol. 83, No. 171 / Tuesday, September 4, 2018 / Notices consumption, with the exception of dietary supplements, medical foods, and foods for special dietary use. This notice applies to foods such as produce, grains, processed foods, food additives, color additives, food contact substances, generally regarded as safe ingredients, infant formula, and all other foods not specifically excluded. Dietary supplements, medical foods, and foods for special dietary use are excluded from this notice. II. Fees To Be Assessed for Export Certificates CFSAN estimates the annual costs of the export certification program for food for human consumption, with the exception of dietary supplements, medical foods, and foods for special dietary use, to be approximately $975,000 per year for preparing and issuing export certificates. The costs are due to payroll and operating expenses. Specifically, there are four cost categories for preparing and issuing export certificates in general: (1) Direct personnel for research, review, tracking, writing, and assembly; (2) an information technology system used for tracking and processing certificates; (3) billing and collection of fees; and (4) overhead and administrative support. In fiscal year (FY) 2017 CFSAN issued approximately 4,072 export certificates for food for human consumption, with the exception of dietary supplements, medical foods, and foods for special dietary use. Because CFSAN has not been charging fees for issuing these export certificates, the program has been covered by appropriated funds. As mentioned previously, FDA may charge up to $175 for each certificate. Certificates for some of the foods that are the subject of this notice cost us more than $175 to prepare. Subsequent certificates issued for the same product(s) in response to the same request generally cost FDA less than $175 to prepare. The fee for all subsequent certificates for the same product(s) issued in response to the same request reflects reduced FDA costs for preparing those certificates. The following fees will be assessed starting October 1, 2018, for export certificates for food for human consumption, with the exception of dietary supplements, medical foods, and foods for special dietary use: ACTION: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. SUMMARY: TABLE 1—CFSAN FEES FOR FIRST, SECOND, AND SUBSEQUENT EXPORT CERTIFICATES Fee (dollars) Type of certificate First certificate ...................... Second certificate for the same product(s) issued in response to the same request ................................. Subsequent certificates for the same product(s) issued in response to the same request .................... Notice. Comments on the ICR must be received on or before October 4, 2018. DATES: 175 Submit your comments to OIRA_submission@omb.eop.gov or via facsimile to (202) 395–5806. ADDRESSES: 155 FOR FURTHER INFORMATION CONTACT: Sherrette Funn, Sherrette.Funn@hhs.gov or (202) 795–7714. When submitting 100 comments or requesting information, please include the document identifier The fee for issuing the first export 4040–0014–30D and project title for certificate for food for human reference. consumption, with the exception of dietary supplements, medical foods, and SUPPLEMENTARY INFORMATION: Interested foods for special dietary use, will be at persons are invited to send comments the maximum allowable amount and regarding this burden estimate or any consistent with the export certification other aspect of this collection of fees assessed since FY 1997 by other information, including any of the FDA Centers that provide export following subjects: (1) The necessity and certification for drugs and devices. It is utility of the proposed information also consistent with the export collection for the proper performance of certification fees assessed by the Center the agency’s functions; (2) the accuracy for Veterinary Medicine (CVM) for certificates for animal food, which CVM of the estimated burden; (3) ways to enhance the quality, utility, and clarity began assessing in FY 2016 because the FSMA amendments to section 801(e)(4) of the information to be collected; and of the FD&C Act also apply to animal (4) the use of automated collection food. The fees for issuing subsequent techniques or other forms of information certificates continue to differ among the technology to minimize the information Centers, based on varying costs. collection burden. Dated: August 28, 2018. Title of the Collections: Federal Leslie Kux, Financial Report (SF–425) and Federal Associate Commissioner for Policy. Financial Report Attachment (SF– [FR Doc. 2018–19064 Filed 8–31–18; 8:45 am] 425A). BILLING CODE 4164–01–P Type of Collection: Extension. OMB No.: 4040–0014. DEPARTMENT OF HEALTH AND Abstract: Federal Financial Report HUMAN SERVICES (SF–425) and Federal Financial Report Attachment (SF–425A) are OMB[Document Identifier: OS–4040–0014] approved collections (4040–0014). Agency Information Collection These information collections are used Request; 30-Day Public Comment by grant awardees. The ICs expire on Request January 31, 2019. We are requesting a three-year clearance of these collections. AGENCY: Office of the Secretary, HHS. sradovich on DSK3GMQ082PROD with NOTICES ESTIMATED ANNUALIZED BURDEN TABLE Average burden hours per response Type of respondent Federal Financial Report (SF–425) ................................ Federal Financial Report Attachment (SF–425A) ........... Grant Applicant .. Grant Applicant .. 100,000 100,000 1 1 1 1 100,000 100,000 Total ......................................................................... ............................ 200,000 ........................ ........................ 200,000 VerDate Sep<11>2014 17:54 Aug 31, 2018 Jkt 244001 PO 00000 Frm 00035 Fmt 4703 Number of respondents Number of responses per respondent Forms Sfmt 4703 E:\FR\FM\04SEN1.SGM 04SEN1 Total burden hours 44892 Federal Register / Vol. 83, No. 171 / Tuesday, September 4, 2018 / Notices Terry Clark, Office of the Secretary, Asst. Paperwork Reduction Act Reports Clearance Officer. [FR Doc. 2018–19084 Filed 8–31–18; 8:45 am] BILLING CODE 4151–AE–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings sradovich on DSK3GMQ082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–6: NCI Clinical and Translational R21 & Omnibus R03. Date: October 4, 2018. Time: 7:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892– 9750, 240–276–7975, chufanee@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–9: NCI Clinical and Translational R21 and Omnibus R03. Date: October 23, 2018. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W114, Bethesda, MD 20892– 9750, 240–276–6371, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee I—Transition to Independence. Date: October 24–25, 2018. VerDate Sep<11>2014 17:54 Aug 31, 2018 Jkt 244001 Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854. Contact Person: Delia Tang, MD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W602, Bethesda, MD 20892–9750, 240–276–6456, tangd@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–8: NCI Clinical and Translational R21 and Omnibus R03. Date: November 1–2, 2018. Time: 6:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Reed A. Graves, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W106, Bethesda, MD 20892– 9750, 240–276–6384, gravesr@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; HIV/AIDS and the Tumor Niche. Date: November 13, 2018. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W618, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W618, Bethesda, MD 20892–9750, 240–276–6611, mukesh.kumar3@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: August 28, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–19051 Filed 8–31–18; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. AGENCY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHScertified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https://www.samhsa.gov/ workplace. FOR FURTHER INFORMATION CONTACT: Charles LoDico, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N02C, Rockville, Maryland 20857; 240–276–2600 (voice). SUPPLEMENTARY INFORMATION: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); April 30, 2010 (75 FR 22809); and on January 23, 2017 (82 FR 7920). The Mandatory Guidelines were initially developed in accordance with SUMMARY: E:\FR\FM\04SEN1.SGM 04SEN1

Agencies

[Federal Register Volume 83, Number 171 (Tuesday, September 4, 2018)]
[Notices]
[Pages 44891-44892]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-19084]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Document Identifier: OS-4040-0014]


Agency Information Collection Request; 30-Day Public Comment 
Request

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995, the Office of the Secretary (OS), Department of Health and 
Human Services, is publishing the following summary of a proposed 
collection for public comment.

DATES: Comments on the ICR must be received on or before October 4, 
2018.

ADDRESSES: Submit your comments to [email protected] or via 
facsimile to (202) 395-5806.

FOR FURTHER INFORMATION CONTACT: Sherrette Funn, [email protected] 
or (202) 795-7714. When submitting comments or requesting information, 
please include the document identifier 4040-0014-30D and project title 
for reference.

SUPPLEMENTARY INFORMATION: Interested persons are invited to send 
comments regarding this burden estimate or any other aspect of this 
collection of information, including any of the following subjects: (1) 
The necessity and utility of the proposed information collection for 
the proper performance of the agency's functions; (2) the accuracy of 
the estimated burden; (3) ways to enhance the quality, utility, and 
clarity of the information to be collected; and (4) the use of 
automated collection techniques or other forms of information 
technology to minimize the information collection burden.
    Title of the Collections: Federal Financial Report (SF-425) and 
Federal Financial Report Attachment (SF-425A).
    Type of Collection: Extension.
    OMB No.: 4040-0014.
    Abstract: Federal Financial Report (SF-425) and Federal Financial 
Report Attachment (SF-425A) are OMB-approved collections (4040-0014). 
These information collections are used by grant awardees. The ICs 
expire on January 31, 2019. We are requesting a three-year clearance of 
these collections.

                                                            Estimated Annualized Burden Table
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
                     Forms                                  Type of respondent               Number of     responses per     hours per     Total burden
                                                                                            respondents     respondent       response          hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Federal Financial Report (SF-425)..............  Grant Applicant........................         100,000               1               1         100,000
Federal Financial Report Attachment (SF-425A)..  Grant Applicant........................         100,000               1               1         100,000
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................         200,000  ..............  ..............         200,000
--------------------------------------------------------------------------------------------------------------------------------------------------------



[[Page 44892]]

Terry Clark,
Office of the Secretary, Asst. Paperwork Reduction Act Reports 
Clearance Officer.
[FR Doc. 2018-19084 Filed 8-31-18; 8:45 am]
 BILLING CODE 4151-AE-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.